PERFORMANCE / SINGLE
IPAMORELIN
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A selective growth-hormone secretagogue studied for stimulating pituitary GH release without significantly affecting ACTH, cortisol or prolactin.
Available Strengths
- 5MG (IP5)
- 10MG (IP10)
Research Protocol
Reference gradual schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.1 mg | 6 | 0.06 mL |
| Weeks 3–4 | 0.15 mg | 9 | 0.09 mL |
| Weeks 5–8 | 0.2 mg | 12 | 0.12 mL |
| Weeks 9–12 | 0.25 mg | 15 | 0.15 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Binds the GHSR-1a receptor to stimulate pulsatile endogenous GH release in the cited research, with selectivity that the studies associate with a more limited hormonal side-effect profile than older secretagogues.
Storage
2–8°C, or −20°C frozen. 2–8°C, use within ~4 weeks.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source